A Comparison of TearCare and Lipiflow Systems in Reducing Dry Eye Disease Symptoms Associated with Meibomian Gland Disease

Overview of attention for article published in Clinical Ophthalmology, August 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#42 of 3,687)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 10 news outlets

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 10 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

LipiFlow for the treatment of dry eye disease

Article in Cochrane Database of Systematic Reviews (February 2024)

A Randomized, Controlled Trial Comparing Tearcare® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA)

Article in Clinical Ophthalmology (December 2023)